Hsp90-associated DNA replication checkpoint protein and proteasome-subunit components are involved i

来源 :中华医学杂志英文版 | 被引量 : 0次 | 上传用户:zhou0168
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background::Age-related macular degeneration (AMD) is the leading cause of vision loss worldwide. However, the mechanisms involved in the development and progression of AMD are poorly delineated. We aimed to explore the critical genes involved in the progression of AMD.Methods::The differentially expressed genes (DEGs) in AMD retinal pigment epithelial (RPE)/choroid tissues were identified using the microarray datasets GSE99248 and GSE125564, which were downloaded from the gene expression omnibus database. The overlapping DEGs from the two datasets were screened to identify DEG-related biological pathways using gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses. The hub genes were identified from these DEGs through protein-protein interaction network analyses. The expression levels of hub genes were evaluated by quantitative real-time polymerase chain reaction following the induction of senescence in ARPE-19 with FK866. Following the identification of AMD-related key genes, the potential small molecule compounds targeting the key genes were predicted by PharmacoDB. Finally, a microRNA-gene interaction network was constructed.Results::Microarray analyses identified 174 DEGs in the AMD RPE compared to the healthy RPE samples. These DEGs were primarily enriched in the pathways involved in the regulation of DNA replication, cell cycle, and proteasome-mediated protein polyubiquitination. Among the top ten hub genes, n HSP90AA1, n CHEK1, n PSMA4, n PSMD4, and n PSMD8 were upregulated in the senescent ARPE-19 cells. Additionally, the drugs targeting HSP90AA1, CHEK1, and PSMA4 were identified. We hypothesize that Hsa-miR-16-5p might target four out of the five key DEGs in the AMD RPE.n Conclusions::Based on our findings, HSP90AA1 is likely to be a central gene controlling the DNA replication and proteasome-mediated polyubiquitination during the RPE senescence observed in the progression of AMD. Targeting n HSP90AA1, n CHEK1, n PSMA4, n PSMD4, and/or n PSMD8 genes through specific miRNAs or small molecules might potentially alleviate the progression of AMD through attenuating RPE senescence.n “,”Background::Age-related macular degeneration (AMD) is the leading cause of vision loss worldwide. However, the mechanisms involved in the development and progression of AMD are poorly delineated. We aimed to explore the critical genes involved in the progression of AMD.Methods::The differentially expressed genes (DEGs) in AMD retinal pigment epithelial (RPE)/choroid tissues were identified using the microarray datasets GSE99248 and GSE125564, which were downloaded from the gene expression omnibus database. The overlapping DEGs from the two datasets were screened to identify DEG-related biological pathways using gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses. The hub genes were identified from these DEGs through protein-protein interaction network analyses. The expression levels of hub genes were evaluated by quantitative real-time polymerase chain reaction following the induction of senescence in ARPE-19 with FK866. Following the identification of AMD-related key genes, the potential small molecule compounds targeting the key genes were predicted by PharmacoDB. Finally, a microRNA-gene interaction network was constructed.Results::Microarray analyses identified 174 DEGs in the AMD RPE compared to the healthy RPE samples. These DEGs were primarily enriched in the pathways involved in the regulation of DNA replication, cell cycle, and proteasome-mediated protein polyubiquitination. Among the top ten hub genes, n HSP90AA1, n CHEK1, n PSMA4, n PSMD4, and n PSMD8 were upregulated in the senescent ARPE-19 cells. Additionally, the drugs targeting HSP90AA1, CHEK1, and PSMA4 were identified. We hypothesize that Hsa-miR-16-5p might target four out of the five key DEGs in the AMD RPE.n Conclusions::Based on our findings, HSP90AA1 is likely to be a central gene controlling the DNA replication and proteasome-mediated polyubiquitination during the RPE senescence observed in the progression of AMD. Targeting n HSP90AA1, n CHEK1, n PSMA4, n PSMD4, and/or n PSMD8 genes through specific miRNAs or small molecules might potentially alleviate the progression of AMD through attenuating RPE senescence.n
其他文献
Background::A deep learning model (DLM) that enables non-invasive hypokalemia screening from an electrocardiogram (ECG) may improve the detection of this life-threatening condition. This study aimed to develop and evaluate the performance of a DLM for the
创面的修复过程需要多种生长因子参与调节,但是目前临床上仍然缺乏强效、长效、价格适中的生长因子制剂,而血小板浓缩制品为临床上创面的治疗提供了一种经济、方便、有效的选择。从第1代血小板浓缩制品富血小板血浆开始,研究人员致力于优化血小板浓缩制品的性能,让其具有更强的稳定性、更丰富的生物活性因子以及更优秀的临床表现,富血小板纤维蛋白和浓缩生长因子应运而生。血小板浓缩制品均具有促进创面愈合、提升创面愈合质量
目的探讨影响脑胶质瘤恶性进展、患者生存预后的关键基因及其在脑胶质瘤中的表达特征和临床意义。方法回顾性分析中国脑胶质瘤基因组图谱(CGGA)RNA测序数据库310例、癌症基因组图谱(TCGA)RNA测序数据库699例、GSE16011 mRNA芯片数据库268例和REMBRANDT mRNA芯片数据库中317例脑胶质瘤患者的临床资料及其脑胶质瘤样本的测序数据,筛选出与患者预后相关的共同差异基因,通过
报道1例非典型EB病毒(Epstein-Barr virus,EBV)感染导致表现为急性肾损伤3期的急性间质性肾炎的儿童罕见病例。本例患儿缺乏典型EBV感染的临床特征,仅表现为反复低热、颈部淋巴结肿大,通过病原宏基因组学检测、特异性抗体检测、EBV-DNA载量测定诊断EBV感染。肾脏病理提示肾小管间质重度急性病变,间质大量炎性细胞浸润,以单个核细胞为主,肾小球轻微病变。18F-氟脱氧葡萄糖(flu
收集上海市同济医院外科重症监护病房中使用oXiris滤器进行连续性肾脏替代治疗的脓毒症急性肾损伤(septic acute kidney injury,SAKI)患者资料,评价oXiris滤器疗效。本研究共纳入7例患者,年龄中位数为71(62,72)岁。与首次oXiris滤器治疗前相比,首次oXiris滤器治疗后患者血清细胞因子白细胞介素(interleukin,IL)-1α、IL-6、IL-10
肝脏病理、肝静脉压力梯度(HVPG)和胃镜检查分别是肝硬化、门静脉高压和食管-胃底静脉曲张的诊断金标准,通常情况下三者表现一致并能体现患者的病因、病变程度和预后风险,但临床工作中也可能出现这3种金标准在同一病例中存在差异的情况。现报道1例酒精性肝病患者3种金标准结果不完全符合时的临床诊疗辨析过程与思考,提示在临床工作中不应局限于某种诊断标准,需提高对疾病整体的全面认识。
盐皮质激素受体的过度激活可促进氧化应激、炎性反应和纤维化,在心血管疾病和慢性肾脏病(chronic kidney disease,CKD)的发生发展中发挥了重要的作用。传统甾体类盐皮质激素受体拮抗剂因低选择性、低亲和力及组织分布带来的不良反应,限制了其临床应用。一系列针对CKD,尤其是CKD合并糖尿病患者的临床研究证实,新型非甾体型高选择性盐皮质激素受体拮抗剂非奈利酮(finerenone)可显著
常染色体显性遗传多囊肾病(autosomal dominant polycystic kidney disease,ADPKD)是导致终末期肾病最常见的遗传病。ADPKD以肾小管上皮细胞失去极性,囊肿进行性增多增大、囊内充满液体为特点,肾功能进行性下降,最终导致终末期肾病。随着对ADPKD研究的深入,我们发现ADPKD具有部分"肿瘤"特性。本文从基因变异、囊肿代谢改变、信号通路、微环境、临床表现及
克罗恩病是炎症性肠病的类型之一,有终身复发倾向。近年来,肿瘤坏死因子-α(TNF-α)单克隆抗体已成为中重度克罗恩病的主要治疗手段,但其不耐受、失应答也较常见,导致长期安全性问题和医疗成本增加。随着研究的不断深入,肠内营养联合TNF-α单克隆抗体治疗可以有效降低成人克罗恩病患者TNF-α单克隆抗体的失应答率,提高诱导缓解、维持缓解率。本文概述了肠内营养联合TNF-α单克隆抗体治疗成人克罗恩病的相关
幽门螺杆菌(H.pylori)感染是消化道常见病,也是目前胃癌预防中最重要的可控危险因素,根除H.pylori可降低胃癌发生风险。我国H.pylori感染率高,耐药形势复杂,含铋剂的四联疗法是我国主要的H.pylori根除方案。近年来,经改良的二联高剂量方案也达到了令人满意的治疗效果,并且具有更好的临床普及性。现对H.pylori根除治疗中的关键问题和近年来国内外常用H.pylori根除治疗方案中